Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Palo Alto Networks
PANW
$260B
| $92.9M | 0.09% |
2,475,516
-420,414
| -15% | -$15.3M |
|
152
Capital One
COF
$130B
| $92.8M | 0.09% |
977,215
-4,871
| -0.5% | -$474K |
|
153
Hexcel
HXL
$8.3B
| $92.7M | 0.09% |
1,382,736
-70,776
| -5% | -$4.8M |
|
|
HRC
154
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $92.4M | 0.09% |
978,335
+312,771
| +47% | +$29.4M |
|
155
Assembly Biosciences
ASMB
$507M
| $92M | 0.08% |
206,432
+464
| +0.2% | +$217K |
|
|
PRAH
156
DELISTED
PRA Health Sciences, Inc.
PRAH
| $91.9M | 0.08% |
834,150
+208,156
| +33% | +$21.7M |
|
157
Teleflex
TFX
$5.94B
| $91.4M | 0.08% |
343,616
+117,279
| +52% | +$30.4M |
|
158
Affiliated Managers Group
AMG
$9.78B
| $91.2M | 0.08% |
667,221
-72,643
| -10% | -$10.7M |
|
159
Starwood Property Trust
STWD
$6.18B
| $91.1M | 0.08% |
4,232,813
-1,442,311
| -25% | -$31.9M |
|
|
EXAS
160
DELISTED
Exact Sciences
EXAS
| $91M | 0.08% |
1,152,986
+186,726
| +19% | +$12.2M |
|
161
Lazard
LAZ
$4.21B
| $90.7M | 0.08% |
1,885,456
-142,048
| -7% | -$7.06M |
|
|
TGE
162
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $89.9M | 0.08% |
3,811,550
+1,116,770
| +41% | +$26.5M |
|
163
CBRE Group
CBRE
$43.1B
| $89.3M | 0.08% |
2,025,630
-457,803
| -18% | -$21.8M |
|
|
PPL
164
PPL Corp
PPL
$27.3B
| $88.6M | 0.08% |
3,029,446
-8,081
| -0.3% | -$236K |
|
165
TC Energy
TRP
$70.5B
| $88.5M | 0.08% |
2,186,985
-244,200
| -10% | -$10.6M |
|
166
Analog Devices
ADI
$178B
| $88.5M | 0.08% |
956,738
-162,706
| -15% | -$15.6M |
|
167
Five Below
FIVE
$11.5B
| $87.9M | 0.08% |
676,040
-639,179
| -49% | -$71.1M |
|
168
Flex
FLEX
$41.5B
| $87.3M | 0.08% |
8,829,693
-2,133,885
| -19% | -$22.3M |
|
169
Natera
NTRA
$36.1B
| $87.2M | 0.08% |
3,641,848
+1,024,225
| +39% | +$24.8M |
|
|
NVRO
170
DELISTED
NEVRO CORP.
NVRO
| $85.6M | 0.08% |
1,501,045
-189,720
| -11% | -$11.9M |
|
|
AERI
171
DELISTED
Aerie Pharmaceuticals
AERI
| $85.3M | 0.08% |
1,386,211
+76,390
| +6% | +$4.91M |
|
|
EE
172
DELISTED
El Paso Electric Company
EE
| $85M | 0.08% |
1,485,429
-98,476
| -6% | -$6.03M |
|
173
Idexx Laboratories
IDXX
$44.9B
| $84.6M | 0.08% |
338,870
+213,132
| +170% | +$51.7M |
|
174
XPO
XPO
$24B
| $84.6M | 0.08% |
2,142,193
-173,432
| -7% | -$6.31M |
|
175
Hilton Worldwide
HLT
$72.6B
| $83.9M | 0.08% |
1,038,068
-559,800
| -35% | -$44.1M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.